SEC Form 4 · accession 0000899243-16-019200
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher M Lindblom
Officer — Principal Accounting Officer
Period of report
May 2, 2016
Accepted (ET)
May 4, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $5.87 | May 2, 2016 | A | 40,000 | A | — | May 2, 2026 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The stock option is an inducement grant pursuant to NASDAQ Stock Market Rule 5635(c)(4).
- F2The option vests as to 12/48th of the shares on April 25, 2017 and vests as to 1/48th of the shares at the end of each calendar month thereafter.